Patents Assigned to Pondera Biotechnologies, LLC
  • NOVEL METHOD TO IMPROVE THE SAFETY AND EFFICACY OF CAFFEINE
    Publication number: 20130197015
    Abstract: The present invention relates to methods and compositions for reducing side effects associated with caffeine consumption. The methods comprise administering a Receptor Switcher, such as N-acetyl cysteine, in combination with caffeine.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 1, 2013
    Applicant: Pondera Biotechnologies, LLC
    Inventor: Pondera Biotechnologies, LLC
  • METHODS AND COMPOSITIONS FOR TREATING DISTRESS DYSFUNCTION AND ENHANCING SAFETY AND EFFICACY OF SPECIFIC MEDICATIONS
    Publication number: 20130156874
    Abstract: The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
    Type: Application
    Filed: February 11, 2013
    Publication date: June 20, 2013
    Applicant: Pondera Biotechnologies, LLC
    Inventor: Pondera Biotechnologies, LLC
  • Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
    Patent number: 8372414
    Abstract: The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: February 12, 2013
    Assignee: Pondera Biotechnologies, LLC
    Inventors: Steven Crain, William E. Crain, Stanley M. Crain, Michael Crain
  • Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
    Patent number: 8202525
    Abstract: The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhancer and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: June 19, 2012
    Assignee: Pondera Biotechnologies, LLC
    Inventors: Steven Crain, William E. Crain, Stanley M. Crain, Michael Crain